UMMS Affiliation

Department of Pediatrics; Program in Molecular Medicine

Date

7-11-2000

Document Type

Article

Subjects

Anti-HIV Agents; CD4 Lymphocyte Count; Child, Preschool; Disease Transmission, Vertical; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Lymphocyte Activation; RNA, Viral; Reverse Transcriptase Inhibitors; T-Lymphocytes, Cytotoxic; Viral Load; Virus Replication

Disciplines

Life Sciences | Medicine and Health Sciences

Abstract

Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate the potential for long-term suppression of viral replication and to evaluate the immune consequences of such therapies. Early combination antiretroviral therapy led to a loss of plasma viremia, cultivable virus, and labile extrachromosomal replication intermediates. Despite preservation of immune function, persistent human immunodeficiency type 1 (HIV-1)-specific immune responses were not detected in most infants. The absence of detectable, persisting immune responses in most HIV-1-infected infants treated early contrasts with what is typically seen in adults who are treated early. These results are consistent with the notion that early combination antiretroviral therapy of HIV-1-infected infants allows the long-term suppression of viral replication.

Rights and Permissions

Citation: J Virol. 2000 Aug;74(15):6984-91.

Related Resources

Link to Article in PubMed

Journal Title

Journal of virology

PubMed ID

10888637

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.